<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">toxreview</journal-id><journal-title-group><journal-title xml:lang="ru">Токсикологический вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Toxicological Review</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-7922</issn><issn pub-type="epub">3034-4611</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36946/0869-7922-2019-6-28-32</article-id><article-id custom-type="elpub" pub-id-type="custom">toxreview-242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>АНТИОКСИДАНТНЫЕ ЭФФЕКТЫ АДЕМЕТИОНИНА ПРИ ВВЕДЕНИИ КРЫСАМ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ В ТОКСИЧЕСКИХ ДОЗАХ</article-title><trans-title-group xml:lang="en"><trans-title>ANTIOXIDANT EFFECTS OF ADEMETIONINE UNDER ADMINISTRATION OF ANTITUBERCULOSIS DRUGS IN TOXIC DOSES TO RATS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Усов</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Usov</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат биологических наук, доцент, заведующий лабораторией токсикологических испытаний и исследований</p><p>665835, г. Ангарск</p></bio><bio xml:lang="en"><p>665835, Angarsk</p></bio><email xlink:type="simple">konstausov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуськова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gus’kova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заслуженный деятель науки РФ, член-корреспондент РАН, доктор медицинских наук, профессор, заместитель Председателя Всероссийской общественной организации токсикологов. Ведущий научный сотрудник отдела доклинических исследований, Ярославский государственный педагогический университет имениК. Д. Ушинского</p><p>150010, г. Ярославль</p></bio><bio xml:lang="en"><p>150010, Yaroslavl</p></bio><email xlink:type="simple">tagus@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юшков</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Jushkov</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент, научный сотрудник </p><p>665835, г. Ангарск</p></bio><bio xml:lang="en"><p>665835, Angarsk</p></bio><email xlink:type="simple">prof_ushkov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ Биофизики, лаборатория токсикологических испытаний и исследований ФГБОУ ВО «Ангарский государственный технический университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Biophysics, Laboratory of Toxicological Tests and Researches, Test Laboratory Center, Angarsk State Technical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Ярославский Центр трансфера фармацевтических технологий</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.V. Dorogov Yaroslavl Center for the Transfer of Pharmaceutical Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2019</year></pub-date><volume>0</volume><issue>6</issue><fpage>28</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Усов К.И., Гуськова Т.А., Юшков Г.Г., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Усов К.И., Гуськова Т.А., Юшков Г.Г.</copyright-holder><copyright-holder xml:lang="en">Usov K.I., Gus’kova T.A., Jushkov G.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.toxreview.ru/jour/article/view/242">https://www.toxreview.ru/jour/article/view/242</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>антиоксидантная система</kwd><kwd>перекисное окисление липидов</kwd><kwd>антиоксидантная защита</kwd><kwd>побочные реакции</kwd><kwd>гептор (адеметионин)</kwd><kwd>противотуберкулезные препараты</kwd><kwd>изониазид</kwd><kwd>рифампицин</kwd><kwd>пиразинамид</kwd><kwd>этамбутол</kwd><kwd>химиотерапия.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>antioxidant system</kwd><kwd>lipid peroxidation</kwd><kwd>antioxidant protection</kwd><kwd>adverse reactions</kwd><kwd>heptor (ademetionine)</kwd><kwd>anti-TB drugs</kwd><kwd>isoniazid</kwd><kwd>rifampicin</kwd><kwd>pyrazinamide</kwd><kwd>ethambutol</kwd><kwd>chemotherapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Зборовская И.А., Банникова М.В. Антиоксидантная система организма, её значение в метаболизме. Клинические аспекты. Вестник российской академии медицинских наук; 1995; (6): 53-60.</mixed-citation><mixed-citation xml:lang="en">Zborovskaya I.A., Bannikova M.V. Antioxidant system of the body, its importance in metabolism. Clinical aspects. Bulletin of the Russian Academy of Medical Sciences, 1995. – Vol. 6. - Pp. 53 – 60 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. (2012). The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol, (10): 49-80.</mixed-citation><mixed-citation xml:lang="en">Agarwal A., Aponte-Mellado A., Premkumar B.J., Shaman A., Gupta S. The effect of oxidative stress on female reproduction: a review. Reprod. Biol. Endocrinol., 2012. – Vol. 10. – Pp. 49 – 80.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Волчегорский И.А., Новоселов П.Н., Болотов А.А. Показатели системы перекисное окисление липидов – антиоксидантная защита как предикторы неблагоприятного течения инфильтративного туберкулеза легких; Проблемы туберкулеза и болезни легких; 2008; 85, (4): 28-32</mixed-citation><mixed-citation xml:lang="en">Volchegorsky I.A., Novoselov P.N., Bolotov A.A. Parameters of the system lipid peroxidation - antioxidant protection as predictors of adverse course of infiltrative pulmonary tuberculosis. Problems of Tuberculosis and Lung Disease, 2008. – Vol. 85. – Iss. 4. Pp. 28 - 32 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Amaral E. P., Conceição E. L., Costa D. L., Rocha M. S., Marinho J. M., CordeiroSantos M., D’Império-Lima M. R., Barbosa T., Sher A., Andrade B. B. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. Amaral et al. BMC Microbiology; 2016 (1): 1-10.</mixed-citation><mixed-citation xml:lang="en">Amaral E.P., Conceição E.L., Costa D.L., Rocha M.S., Marinho J.M., Cordeiro-Santos M., D’Império-Lima M.R., Barbosa T., Sher A., Andrade B.B. N-Acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. Amaral et al. BMC Microbiology, 2016. - Vol. 1. – Pp. 1 - 10.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Усов К.И., Юшков Г.Г., Шульгина Н.А., Седых Е.О. Сравнительное исследование биохимических процессов нарушения метаболизма триптофана при воздействии изониазидом и изониазидом в комбинации с витамином В6 в условиях эксперимента. Вестник ангарской государственной технической академии; 2009; 3, (1): 140-143.</mixed-citation><mixed-citation xml:lang="en">Usov K.I., Yushkov G.G., Shul’gina N.A., Sedykh E.O. Comparative study of biochemical processes of metabolic disorders of tryptophan under the influence of isoniazid and isoniazid in combination with vitamin B6 in experimental conditions. Bulletin of the Angarsk State Technical Academy, 2009. – Vol. 3. – Iss. 1. Pp. 140 - 143 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma R, Goyal N, Singla M, Sharma V.L. Berberis aristata Ameliorates Testicular Toxicity Induced by Combination of FirstLine Tuberculosis Drugs (Rifampicin + Isoniazid + Pyrazinamide) in Normal Wistar Rats. J. Diet Suppl; 2018 Jun (28): 1-14.</mixed-citation><mixed-citation xml:lang="en">Sharma R., Goyal N., Singla M., Sharma V.L. Berberis aristata ameliorates testicular toxicity induced by combination of first-line tuberculosis drugs (rifampicin + isoniazid + pyrazinamide) in normal Wistar Rats. J. Diet Suppl, 2018. – Vol. 28. – Pp. 1-14.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Есимова И. Е. Состояние липидной фазы мембраны мононуклеарных клеток крови при туберкулезе легких: автореф. дис. … канд. мед. наук. И. Е. Есимова. Томск, 2007. – 42 с.</mixed-citation><mixed-citation xml:lang="en">Yesimova I.E. Status of the lipid phase of a membrane of mononuclear blood cells in pulmonary tuberculosis. PhD thesis, 2007. - Tomsk. - 42 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Зиновьев И. П. При стандартной химиотерапии больных туберкулезом лекарственная устойчивость Mycobacterium tuberculosis возникает внутри фагоцита. Тезисы докладов XII Российского национального конгресса «Человек и лекарство». М., 2005. – С. 121.</mixed-citation><mixed-citation xml:lang="en">Zinov’ev I.P. With standard chemotherapy of tuberculosis patients, drug resistance of Mycobacterium tuberculosis occurs inside the phagocyte. Abstracts of the XII Russian National Congress “Man and Medicine”, 2005. Moscow. – P. 121 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гурьева И. Г., Андржеюк Н. И., Смирнова Н. А. Биохимическое обоснование применения патогенетической терапии при туберкулезе легких. Проблемы туберкулеза; 1978; (11): 27-30.</mixed-citation><mixed-citation xml:lang="en">Gur’eva I.G., Andrzheyuk N.I., Smirnova N.A. Biochemical substantiation of the use of pathogenetic therapy in pulmonary tuberculosis. Problems of Tuberculosis, 1978. – Vol. 11.- Pp. 27 – 30 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Челнокова Н.В., Мишин В.Ю., Васильева И.А. Частота и характер побочных реакций при различных режимах химиотерапии // 3 съезд научно-медицинской ассоциации фтизиатров. Сборник резюме. Екатеринбург; 1997. – С.37</mixed-citation><mixed-citation xml:lang="en">Chelnokova N.V., Mishin V.Yu., Vasilyeva I.A. Frequency and nature of adverse reactions in different chemotherapy regimens. Abstracts of the 3rd Congress of the Scientific Medical Association of Phthisiologists. Ekaterinburg, 1997. – P. 37 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Усов К. И., Гуськова Т. А., Юшков Г. Г., Гришина Л. П., Гущин А. С. Экспериментальное обоснование терапии сопровождения с применением адеметионина для снижения гепатотоксических реакций противотуберкулезных препаратов. Токсикологический вестник; 2018; (6): 12-21.</mixed-citation><mixed-citation xml:lang="en">Usov K.I., Gus’kova T.A., Yushkov G.G., Grishina L.P., Gushchin A.S. Experimental substantiation of accompaniment therapy with the use of ademetionine to reduce hepatotoxic reactions of anti-tuberculosis drugs. Toxicological Bulletin, 2018. Vol. 6.-Pp. 12-21 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Топчий Н.В., Топорков А.С. Гепатотоксичность – наиболее вероятные причины и возможности оптимальной коррекции гептралом. РМЖ; 2013; 21 (5): 249-257</mixed-citation><mixed-citation xml:lang="en">Topchiy N.V., Toporkov A.S. Hepatotoxicity – the most probable causes and possibilities of optimal correction with heptral. Russian Medical Journal, 2013.- Vol. 21. – Iss. – 5. – Pp. 249 – 257 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по проведению доклинических исследований лекарственных средств. Часть первая. Под ред. А.Н. Миронова; М.: Гриф и К, 2012. – 944 с.</mixed-citation><mixed-citation xml:lang="en">The guidelines for preclinical studies of pharmaceuticals. Part one. Edited by Mironov A.N. M.: Grif and K, 2012. - 944 p (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Гуськова Т. А. Токсикология лекарственных средств. М.: МДВ., 2008. – 196 с.</mixed-citation><mixed-citation xml:lang="en">Gus’kova T. A. Toxicology of drugs. M.: MDV., 2008. - 196 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Суханов Д.С., Виноградова Т.И., Заболотных Н.В., Витовская М.Л., Коваленко А.Л. Гепатотропное действие рунихола и адеметионина при повреждении печени противотуберкулезными препаратами основного ряда в эксперименте. Архив патологии. 2014; 76 (2): 26-31.</mixed-citation><mixed-citation xml:lang="en">Sukhanov D.S., Vinogradova T.I., Zabolotnykh N.V., Vitovskaya M.L., Kovalenko A.L. Hepatotropic effect of runichol and ademetionin in liver damage with anti-tuberculosis drugs of the main series in the experiment. Archives of pathology, 2014. – Vol. 76. – Iss. 2. Pp. 26 – 31 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилов В.Б., Мишкорудная М.И. Спектрофотометрическое определение содержания гидроперекисей липидов в плазме крови. Лабораторное дело; 1983; (3): 33-36.</mixed-citation><mixed-citation xml:lang="en">Gavrilov V.B., Mishkorudnaya M.I. Spectrophotometric determination of lipid hydroperoxides in blood plasma. Laboratory Practice, 1983.- Vol. 3. Pp. 33 – 36 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Стальная И.Д., Гаришвили Т.Г. Метод определения малонового диальдегида с помощью тиобарбитуровой кислоты. Современные методы в биохимии. Под ред. В.Н. Ореховича; М.: Медицина, 1977. – С. 66-68</mixed-citation><mixed-citation xml:lang="en">Stal’naya I.D., Garishvili T.G. Method of the determination of malon dialdehyde using thiobarbituric acid. Modern Methods in Biochemistry. Edited by Orekhovich V.N. M.: Medicine, 1977. - Pp. 66 – 68 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Портяная Н.И., Осипенко Б.Г., Москадынова П.А. Биохимические исследования в токсикологическом эксперименте. Под ред. М.Ф. Савченкова, В.М. Прусакова. – Иркутск: Изд-во ИГУ, 1990. – 216 с.</mixed-citation><mixed-citation xml:lang="en">Portyanaya N.I., Osipenko B.G., Moskadynova P.A. Biochemical studies in toxicological experiment. Edited by Savchenkov M.F., Prusakov V.M. Irkutsk: ISU, 1990. - 216 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sedlak J., Lindsay R.H. Estimation of total proteinbound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem; 1968; (25): 192-205</mixed-citation><mixed-citation xml:lang="en">Sedlak J., Lindsay R.H. Estimation of total proteinbound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem., 1968. – Vol. 25.- Pp. 192 – 205 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Festing MF.W., Altman D.G. Guodelines for the Design and Statistical Analysis of Experiments Using Laboratory Animals. ILAR Journal; 2002; 43 (4): 244-258.</mixed-citation><mixed-citation xml:lang="en">Festing MF.W., Altman D.G. Guodelines for the Design and Statistical Analysis of Experiments Using Laboratory Animals. ILAR Journal, 2002. – Vol. 43. – Iss. 4.- Pp. 244 – 258 (in Russian)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
